Stable Isotope Labeled Compounds Market by Type (Carbon 13, D, Oxygen 18, N15), Application (Research, Clinical Diagnostics, Industrial), End User (Pharmaceutical & Biopharmaceutical Companies, Academic institute), Region – Global Forecast to 2024
“The stable isotope labeled compounds market is projected to grow at a CAGR of 3.0% during the forecast period (2019–2024).”
The global stable isotope labeled compounds market size is projected to reach USD 312 million by 2024 from USD 269 million in 2019, at a CAGR of 3.0%. The growth of this market is driven majorly by factors such as the increase in research activities in the pharmaceutical and biotechnology sector, rising proteomics research, and the rising prevalence of cancer. However, the high cost of stable isotope-labeled compounds is expected to restrain the growth of this market during the forecast period.
“By type, the H-2 labeled compounds segment is expected to grow at the highest CAGR during the forecast period.”
Based on component, the stable isotope-labeled compounds market is segmented into C-13, N-15, O-18, H-2 (deuterium), and other isotopes. The H-2 labeled compounds segment accounted for the largest market share in 2018. This segment is also expected to register the highest growth during the forecast period. This growth in this segment is driven primarily by growing drug research in the pharmaceutical industry and the increasing availability of deuterium-labeled compounds.
“By application, the research segment dominated the stable isotope labeled compounds market in 2018.”
Based on technology, the stable isotope-labeled compounds market is segmented into research, clinical diagnostics, industrial applications, and other applications. The research segment accounted for the largest share of the stable isotope-labeled compounds market in 2018, owing to rising research activities in the biomedical, pharmaceutical, environmental & ecological, and agricultural sectors.
“North America stable isotope labeled compounds market is expected to witness the highest growth during the forecast period.”
The North America region market is estimated to grow at the highest CAGR during the forecast period, primarily due to the growing pharmaceutical and biopharmaceutical industry, support from the Isotope Production and Distribution Program Fund, and the presence of a large nuclear industry are driving market growth in the region.
A breakdown of the primary participants referred to for this report is provided below:
Research Coverage:
The report analyzes the stable isotope labeled compounds market and aims at estimating the market size and future growth potential. The report also includes an in-depth competitive analysis of the key players in this market, along with their company profiles, product offerings, and recent developments.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a greater share. Firms purchasing the report could use one, or a combination of the below mentioned five strategies for strengthening their market presence.
This report provides insights on the following pointers:
The global stable isotope labeled compounds market size is projected to reach USD 312 million by 2024 from USD 269 million in 2019, at a CAGR of 3.0%. The growth of this market is driven majorly by factors such as the increase in research activities in the pharmaceutical and biotechnology sector, rising proteomics research, and the rising prevalence of cancer. However, the high cost of stable isotope-labeled compounds is expected to restrain the growth of this market during the forecast period.
“By type, the H-2 labeled compounds segment is expected to grow at the highest CAGR during the forecast period.”
Based on component, the stable isotope-labeled compounds market is segmented into C-13, N-15, O-18, H-2 (deuterium), and other isotopes. The H-2 labeled compounds segment accounted for the largest market share in 2018. This segment is also expected to register the highest growth during the forecast period. This growth in this segment is driven primarily by growing drug research in the pharmaceutical industry and the increasing availability of deuterium-labeled compounds.
“By application, the research segment dominated the stable isotope labeled compounds market in 2018.”
Based on technology, the stable isotope-labeled compounds market is segmented into research, clinical diagnostics, industrial applications, and other applications. The research segment accounted for the largest share of the stable isotope-labeled compounds market in 2018, owing to rising research activities in the biomedical, pharmaceutical, environmental & ecological, and agricultural sectors.
“North America stable isotope labeled compounds market is expected to witness the highest growth during the forecast period.”
The North America region market is estimated to grow at the highest CAGR during the forecast period, primarily due to the growing pharmaceutical and biopharmaceutical industry, support from the Isotope Production and Distribution Program Fund, and the presence of a large nuclear industry are driving market growth in the region.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1–21%, Tier 2–26%, and Tier 3–53%
- By Designation: C-level–32%, Director-level–26%, and Others–42%
- By Region: North America–34%, Europe–29%, Asia Pacific–27%, RoW-10%
Research Coverage:
The report analyzes the stable isotope labeled compounds market and aims at estimating the market size and future growth potential. The report also includes an in-depth competitive analysis of the key players in this market, along with their company profiles, product offerings, and recent developments.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a greater share. Firms purchasing the report could use one, or a combination of the below mentioned five strategies for strengthening their market presence.
This report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the stable isotope labeled compounds market
- Service Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the stable isotope labeled compounds market
- Market Development: Comprehensive information on lucrative emerging regions
- Market Diversification: Exhaustive information about new systems, growing geographies, and recent developments in the global stable isotope labeled compounds market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, revenue analysis, and services of the leading players in the stable isotope labeled compounds market
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 MARKET SCOPE
1.2.2 MARKETS COVERED
1.2.3 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
1.4 LIMITATIONS
1.5 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.2 SECONDARY DATA
2.2.1 KEY DATA FROM SECONDARY SOURCES
2.3 PRIMARY DATA
2.3.1 KEY DATA FROM PRIMARY SOURCES
2.4 MARKET SIZE ESTIMATION
2.4.1 REVENUE MAPPING-BASED MARKET ESTIMATION
2.5 DATA TRIANGULATION
2.5.1 ASSUMPTIONS FOR THE STUDY
2.5.2 LIMITATIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 STABLE ISOTOPE-LABELED COMPOUNDS MARKET OVERVIEW
4.2 NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION (2018)
4.3 GEOGRAPHICAL SNAPSHOT OF THE STABLE ISOTOPE-LABELED COMPOUNDS MARKET
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increase in research activities in the pharmaceutical & biotechnology sectors
5.2.1.2 Growing proteomics research
5.2.1.3 Growing prevalence of cancer
5.2.2 RESTRAINTS
5.2.2.1 High cost of stable isotope-labeled compounds
5.2.3 OPPORTUNITIES
5.2.3.1 Growing investments in pharmaceutical R&D in emerging markets
5.2.4 CHALLENGES
5.2.4.1 Dearth of skilled professionals
6 STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE
6.1 INTRODUCTION
6.2 HYDROGEN-2
6.2.1 GROWING APPLICATIONS OF H-2 IN PHARMACEUTICAL RESEARCH WILL DRIVE THE DEMAND FOR LABELED COMPOUNDS
6.3 CARBON-13
6.3.1 GROWING NUMBER OF METABOLOMICS STUDIES AND APPLICATIONS IN DISEASE DIAGNOSIS ARE DRIVING MARKET GROWTH
6.4 OXYGEN-18
6.4.1 INCREASING RESEARCH ON CANCER IS EXPECTED TO DRIVE THE DEMAND FOR OXYGEN-18-LABELED ISOTOPES
6.5 NITROGEN-15
6.5.1 EXPANDING APPLICATIONS OF N-15 IN AGRICULTURAL INVESTIGATION AND RISING RESEARCH ARE LIKELY TO DRIVE MARKET DEMAND
6.6 OTHER STABLE ISOTOPES
7 STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 RESEARCH APPLICATIONS
7.2.1 BIOMEDICAL RESEARCH
7.2.1.1 Increasing number of biomedical research activities involving stable isotopes to drive the stable isotope-labeled compounds market for biomedical research
7.2.2 PHARMACEUTICAL RESEARCH
7.2.2.1 Stable isotopically modified pharmaceutical agents offer reduced side-effects, improved oral bioavailability, and increased half-life—key factors driving market growth
7.2.3 ENVIRONMENTAL & ECOLOGICAL RESEARCH
7.2.3.1 Increasing use of stable to study the feeding ecology of living or extinct animal species through the analysis of their ratios in carcasses or remains to drive market growth
7.2.4 AGRICULTURAL RESEARCH
7.2.4.1 Increasing use of stable isotopes to prevent soil pollution and contamination and facilitate maximum crop production to drive growth in this market
7.3 CLINICAL DIAGNOSTICS
7.3.1 INCREASING ADOPTION OF PET SCANS AND GAMMA IMAGING FOR DISEASE STAGING TO SUPPORT MARKET GROWTH
7.4 INDUSTRIAL APPLICATIONS
7.4.1 GROWING APPLICATION OF STABLE ISOTOPES IN THE NUCLEAR INDUSTRY AND THE INCREASING NUMBER OF NUCLEAR REACTORS TO SUPPORT MARKET GROWTH
7.5 OTHER APPLICATIONS
8 STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER
8.1 INTRODUCTION
8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
8.2.1 INCREASE IN R&D ACTIVITIES TO DRIVE THE DEMAND FOR STABLE ISOTOPE-LABELED COMPOUNDS AMONG PHARMA & BIOTECH COMPANIES
8.3 ACADEMIC & RESEARCH INSTITUTES
8.3.1 GROWING RESEARCH ON VARIOUS TREATMENT THERAPIES IS DRIVING THE GROWTH OF THIS END-USER SEGMENT
8.4 HOSPITALS & DIAGNOSTIC CENTERS
8.4.1 ADOPTION OF STABLE ISOTOPES HAS INCREASED OWING TO THE RISING PREVALENCE OF TARGET DISEASES
8.5 OTHER END USERS
9 STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 US
9.2.1.1 The US dominates the North American stable isotope-labeled compounds market
9.2.2 CANADA
9.2.2.1 Availability of funding will drive the market in Canada
9.3 EUROPE
9.3.1 GERMANY
9.3.1.1 Germany is the fastest-growing market in Europe
9.3.2 UK
9.3.2.1 Favorable scenario for environmental research and increasing prevalence of cancer are key growth drivers in the UK
9.3.3 FRANCE
9.3.3.1 France has a large and well-developed biotech industry
9.3.4 ITALY
9.3.4.1 Strong government support for research has stimulated market growth in Italy
9.3.5 SPAIN
9.3.5.1 Increasing research activities and expenditure shows significant market growth potential in Spain
9.3.6 REST OF EUROPE
9.4 ASIA PACIFIC
9.4.1 CHINA
9.4.1.1 China dominates the stable isotope-labeled compounds market in the APAC
9.4.2 JAPAN
9.4.2.1 Growing support and funding have raised research intensity in Japan
9.4.3 INDIA
9.4.3.1 Government initiatives have strengthened the life science industry in India
9.4.4 AUSTRALIA
9.4.4.1 Growing funding for research and collaborations have supported market growth in Australia
9.4.5 REST OF ASIA PACIFIC
9.5 REST OF THE WORLD
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 MARKET SHARE ANALYSIS, 2018
10.3 COMPETITIVE SCENARIO
10.4 COMPETITIVE LEADERSHIP MAPPING (2018)
10.4.1 VISIONARY LEADERS
10.4.2 INNOVATORS
10.4.3 DYNAMIC DIFFERENTIATORS
10.4.4 EMERGING COMPANIES
11 COMPANY PROFILES
(Business Overview, Products Offered, Recent Developments, Competitive Analysis, MnM View)*
11.1 CAMBRIDGE ISOTOPE LABORATORIES
11.2 MERCK KGAA
11.3 URENCO LIMITED
11.4 ISOSCIENCES
11.5 MEDICAL ISOTOPES
11.6 OMICRON BIOCHEMICALS
11.7 TRACE SCIENCES INTERNATIONAL
11.8 ALSACHIM
11.9 TAIYO NIPPON SANSO CORPORATION
11.10 PERKINELMER
11.11 ROTEM INDUSTRIES ISRAEL
11.12 BOC SCIENCES
11.13 CORTECNET
11.14 ISOFLEX
11.15 HUAYI ISOTOPES CO.
11.16 MESBAH ENERGY CO.
11.17 SHANGHAI RESEARCH INSTITUTE OF CHEMICAL INDUSTRY
11.18 13C MOLECULAR
11.19 C/D/N ISOTOPES
11.20 SHOKO CO.
*Business Overview, Products Offered, Recent Developments, Competitive Analysis, MnM View might not be captured in case of unlisted companies.
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 MARKET SCOPE
1.2.2 MARKETS COVERED
1.2.3 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
1.4 LIMITATIONS
1.5 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.2 SECONDARY DATA
2.2.1 KEY DATA FROM SECONDARY SOURCES
2.3 PRIMARY DATA
2.3.1 KEY DATA FROM PRIMARY SOURCES
2.4 MARKET SIZE ESTIMATION
2.4.1 REVENUE MAPPING-BASED MARKET ESTIMATION
2.5 DATA TRIANGULATION
2.5.1 ASSUMPTIONS FOR THE STUDY
2.5.2 LIMITATIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 STABLE ISOTOPE-LABELED COMPOUNDS MARKET OVERVIEW
4.2 NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION (2018)
4.3 GEOGRAPHICAL SNAPSHOT OF THE STABLE ISOTOPE-LABELED COMPOUNDS MARKET
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increase in research activities in the pharmaceutical & biotechnology sectors
5.2.1.2 Growing proteomics research
5.2.1.3 Growing prevalence of cancer
5.2.2 RESTRAINTS
5.2.2.1 High cost of stable isotope-labeled compounds
5.2.3 OPPORTUNITIES
5.2.3.1 Growing investments in pharmaceutical R&D in emerging markets
5.2.4 CHALLENGES
5.2.4.1 Dearth of skilled professionals
6 STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE
6.1 INTRODUCTION
6.2 HYDROGEN-2
6.2.1 GROWING APPLICATIONS OF H-2 IN PHARMACEUTICAL RESEARCH WILL DRIVE THE DEMAND FOR LABELED COMPOUNDS
6.3 CARBON-13
6.3.1 GROWING NUMBER OF METABOLOMICS STUDIES AND APPLICATIONS IN DISEASE DIAGNOSIS ARE DRIVING MARKET GROWTH
6.4 OXYGEN-18
6.4.1 INCREASING RESEARCH ON CANCER IS EXPECTED TO DRIVE THE DEMAND FOR OXYGEN-18-LABELED ISOTOPES
6.5 NITROGEN-15
6.5.1 EXPANDING APPLICATIONS OF N-15 IN AGRICULTURAL INVESTIGATION AND RISING RESEARCH ARE LIKELY TO DRIVE MARKET DEMAND
6.6 OTHER STABLE ISOTOPES
7 STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 RESEARCH APPLICATIONS
7.2.1 BIOMEDICAL RESEARCH
7.2.1.1 Increasing number of biomedical research activities involving stable isotopes to drive the stable isotope-labeled compounds market for biomedical research
7.2.2 PHARMACEUTICAL RESEARCH
7.2.2.1 Stable isotopically modified pharmaceutical agents offer reduced side-effects, improved oral bioavailability, and increased half-life—key factors driving market growth
7.2.3 ENVIRONMENTAL & ECOLOGICAL RESEARCH
7.2.3.1 Increasing use of stable to study the feeding ecology of living or extinct animal species through the analysis of their ratios in carcasses or remains to drive market growth
7.2.4 AGRICULTURAL RESEARCH
7.2.4.1 Increasing use of stable isotopes to prevent soil pollution and contamination and facilitate maximum crop production to drive growth in this market
7.3 CLINICAL DIAGNOSTICS
7.3.1 INCREASING ADOPTION OF PET SCANS AND GAMMA IMAGING FOR DISEASE STAGING TO SUPPORT MARKET GROWTH
7.4 INDUSTRIAL APPLICATIONS
7.4.1 GROWING APPLICATION OF STABLE ISOTOPES IN THE NUCLEAR INDUSTRY AND THE INCREASING NUMBER OF NUCLEAR REACTORS TO SUPPORT MARKET GROWTH
7.5 OTHER APPLICATIONS
8 STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER
8.1 INTRODUCTION
8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
8.2.1 INCREASE IN R&D ACTIVITIES TO DRIVE THE DEMAND FOR STABLE ISOTOPE-LABELED COMPOUNDS AMONG PHARMA & BIOTECH COMPANIES
8.3 ACADEMIC & RESEARCH INSTITUTES
8.3.1 GROWING RESEARCH ON VARIOUS TREATMENT THERAPIES IS DRIVING THE GROWTH OF THIS END-USER SEGMENT
8.4 HOSPITALS & DIAGNOSTIC CENTERS
8.4.1 ADOPTION OF STABLE ISOTOPES HAS INCREASED OWING TO THE RISING PREVALENCE OF TARGET DISEASES
8.5 OTHER END USERS
9 STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 US
9.2.1.1 The US dominates the North American stable isotope-labeled compounds market
9.2.2 CANADA
9.2.2.1 Availability of funding will drive the market in Canada
9.3 EUROPE
9.3.1 GERMANY
9.3.1.1 Germany is the fastest-growing market in Europe
9.3.2 UK
9.3.2.1 Favorable scenario for environmental research and increasing prevalence of cancer are key growth drivers in the UK
9.3.3 FRANCE
9.3.3.1 France has a large and well-developed biotech industry
9.3.4 ITALY
9.3.4.1 Strong government support for research has stimulated market growth in Italy
9.3.5 SPAIN
9.3.5.1 Increasing research activities and expenditure shows significant market growth potential in Spain
9.3.6 REST OF EUROPE
9.4 ASIA PACIFIC
9.4.1 CHINA
9.4.1.1 China dominates the stable isotope-labeled compounds market in the APAC
9.4.2 JAPAN
9.4.2.1 Growing support and funding have raised research intensity in Japan
9.4.3 INDIA
9.4.3.1 Government initiatives have strengthened the life science industry in India
9.4.4 AUSTRALIA
9.4.4.1 Growing funding for research and collaborations have supported market growth in Australia
9.4.5 REST OF ASIA PACIFIC
9.5 REST OF THE WORLD
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 MARKET SHARE ANALYSIS, 2018
10.3 COMPETITIVE SCENARIO
10.4 COMPETITIVE LEADERSHIP MAPPING (2018)
10.4.1 VISIONARY LEADERS
10.4.2 INNOVATORS
10.4.3 DYNAMIC DIFFERENTIATORS
10.4.4 EMERGING COMPANIES
11 COMPANY PROFILES
(Business Overview, Products Offered, Recent Developments, Competitive Analysis, MnM View)*
11.1 CAMBRIDGE ISOTOPE LABORATORIES
11.2 MERCK KGAA
11.3 URENCO LIMITED
11.4 ISOSCIENCES
11.5 MEDICAL ISOTOPES
11.6 OMICRON BIOCHEMICALS
11.7 TRACE SCIENCES INTERNATIONAL
11.8 ALSACHIM
11.9 TAIYO NIPPON SANSO CORPORATION
11.10 PERKINELMER
11.11 ROTEM INDUSTRIES ISRAEL
11.12 BOC SCIENCES
11.13 CORTECNET
11.14 ISOFLEX
11.15 HUAYI ISOTOPES CO.
11.16 MESBAH ENERGY CO.
11.17 SHANGHAI RESEARCH INSTITUTE OF CHEMICAL INDUSTRY
11.18 13C MOLECULAR
11.19 C/D/N ISOTOPES
11.20 SHOKO CO.
*Business Overview, Products Offered, Recent Developments, Competitive Analysis, MnM View might not be captured in case of unlisted companies.
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
LIST OF TABLES
TABLE 1 COMPANY DRUG PIPELINES, 2019
TABLE 2 TOP INVESTORS IN R&D, 2016 VS. 2017
TABLE 3 GLOBAL CANCER INCIDENCE, 2018 VS. 2025
TABLE 4 GOVERNMENT FUNDING PROGRAMS FOR PHARMACEUTICAL R&D IN EMERGING NATIONS
TABLE 5 STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 6 HYDROGEN-2-LABELED COMPOUNDS MARKET, BY REGION, 2017–2022 (USD MILLION)
TABLE 7 NORTH AMERICA: HYDROGEN-2-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 8 EUROPE: HYDROGEN-2-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 9 APAC: HYDROGEN-2-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 10 CARBON-13-LABELED COMPOUNDS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 11 NORTH AMERICA: CARBON-13-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 12 EUROPE: CARBON-13-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 13 APAC: C CARBON-13-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 14 OXYGEN-18-LABELED COMPOUNDS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 15 NORTH AMERICA: OXYGEN-18-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 16 EUROPE: OXYGEN-18-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 17 APAC: OXYGEN-18-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 18 NITROGEN-15-LABELED COMPOUNDS MARKET, BY REGION, 2017–2022 (USD MILLION)
TABLE 19 NORTH AMERICA: NITROGEN-15-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 20 EUROPE: NITROGEN-15-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 21 APAC: NITROGEN-15-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 22 OTHER STABLE ISOTOPES MARKET, BY REGION, 2017–2022 (USD THOUSAND)
TABLE 23 NORTH AMERICA: OTHER STABLE ISOTOPES MARKET, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 24 EUROPE: OTHER STABLE ISOTOPES MARKET, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 25 APAC: OTHER STABLE ISOTOPES MARKET, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 26 STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 27 STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2017–2024 (USD MILLION)
TABLE 28 NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 29 EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 30 APAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 31 STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2017–2024 (USD MILLION)
TABLE 32 NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 33 EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 34 APAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 35 STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION, 2017–2024 (USD MILLION)
TABLE 36 NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 37 EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 38 APAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 39 STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR OTHER APPLICATIONS, BY REGION, 2017–2024 (USD MILLION)
TABLE 40 NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 41 EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 42 APAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 43 STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 44 STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2017–2024 (USD MILLION)
TABLE 45 NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 46 EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 47 APAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 48 STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2017–2024 (USD MILLION)
TABLE 49 NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 50 EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 51 APAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 52 STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2015–2022 (USD MILLION)
TABLE 53 NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 54 EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 55 APAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 56 STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR OTHER END USERS, BY REGION, 2015–2022 (USD MILLION)
TABLE 57 NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR OTHER END USERS, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 58 EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR OTHER END USERS, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 59 APAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR OTHER END USERS, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 60 STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 61 NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 62 NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 63 NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 64 NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 65 US: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 66 US: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 67 US: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 68 CANADA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD THOUSAND)
TABLE 69 CANADA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD THOUSAND)
TABLE 70 CANADA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD THOUSAND)
TABLE 71 EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 72 EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 73 EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 74 EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 75 GERMANY: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 76 GERMANY: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 77 GERMANY: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 78 UK: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 79 UK: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 80 UK: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 81 FRANCE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD THOUSAND)
TABLE 82 FRANCE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD THOUSAND)
TABLE 83 FRANCE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2015–2022 (USD THOUSAND)
TABLE 84 ITALY: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD THOUSAND)
TABLE 85 ITALY: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD THOUSAND)
TABLE 86 ITALY: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD THOUSAND)
TABLE 87 SPAIN: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD THOUSAND)
TABLE 88 SPAIN: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD THOUSAND)
TABLE 89 SPAIN: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD THOUSAND)
TABLE 90 PHARMACEUTICAL R&D EXPENDITURE IN ROE COUNTRIES (2016)
TABLE 91 ROE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD THOUSAND)
TABLE 92 ROE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD THOUSAND)
TABLE 93 ROE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD THOUSAND)
TABLE 94 NUMBER OF NUCLEAR REACTORS IN THE ASIA PACIFIC (AUGUST 2019)
TABLE 95 ASIA PACIFIC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 96 ASIA PACIFIC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 97 ASIA PACIFIC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 98 ASIA PACIFIC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE 99 CHINA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 100 CHINA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 101 CHINA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 102 JAPAN: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD THOUSAND)
TABLE 103 JAPAN: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2015–2022 (USD THOUSAND)
TABLE 104 JAPAN: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD THOUSAND)
TABLE 105 INDIA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD THOUSAND)
TABLE 106 INDIA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD THOUSAND)
TABLE 107 INDIA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD THOUSAND)
TABLE 108 AUSTRALIA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD THOUSAND)
TABLE 109 AUSTRALIA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD THOUSAND)
TABLE 110 AUSTRALIA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD THOUSAND)
TABLE 111 ROAPAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD THOUSAND)
TABLE 112 ROAPAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD THOUSAND)
TABLE 113 ROAPAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD THOUSAND)
TABLE 114 ROW: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD THOUSAND)
TABLE 115 ROW: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD THOUSAND)
TABLE 116 ROW: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD THOUSAND)
TABLE 117 AGREEMENTS (2016–2019)
TABLE 118 PRODUCT LAUNCHES (2016-2019)
TABLE 1 COMPANY DRUG PIPELINES, 2019
TABLE 2 TOP INVESTORS IN R&D, 2016 VS. 2017
TABLE 3 GLOBAL CANCER INCIDENCE, 2018 VS. 2025
TABLE 4 GOVERNMENT FUNDING PROGRAMS FOR PHARMACEUTICAL R&D IN EMERGING NATIONS
TABLE 5 STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 6 HYDROGEN-2-LABELED COMPOUNDS MARKET, BY REGION, 2017–2022 (USD MILLION)
TABLE 7 NORTH AMERICA: HYDROGEN-2-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 8 EUROPE: HYDROGEN-2-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 9 APAC: HYDROGEN-2-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 10 CARBON-13-LABELED COMPOUNDS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 11 NORTH AMERICA: CARBON-13-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 12 EUROPE: CARBON-13-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 13 APAC: C CARBON-13-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 14 OXYGEN-18-LABELED COMPOUNDS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 15 NORTH AMERICA: OXYGEN-18-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 16 EUROPE: OXYGEN-18-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 17 APAC: OXYGEN-18-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 18 NITROGEN-15-LABELED COMPOUNDS MARKET, BY REGION, 2017–2022 (USD MILLION)
TABLE 19 NORTH AMERICA: NITROGEN-15-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 20 EUROPE: NITROGEN-15-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 21 APAC: NITROGEN-15-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 22 OTHER STABLE ISOTOPES MARKET, BY REGION, 2017–2022 (USD THOUSAND)
TABLE 23 NORTH AMERICA: OTHER STABLE ISOTOPES MARKET, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 24 EUROPE: OTHER STABLE ISOTOPES MARKET, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 25 APAC: OTHER STABLE ISOTOPES MARKET, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 26 STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 27 STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2017–2024 (USD MILLION)
TABLE 28 NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 29 EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 30 APAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 31 STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2017–2024 (USD MILLION)
TABLE 32 NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 33 EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 34 APAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 35 STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION, 2017–2024 (USD MILLION)
TABLE 36 NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 37 EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 38 APAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 39 STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR OTHER APPLICATIONS, BY REGION, 2017–2024 (USD MILLION)
TABLE 40 NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 41 EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 42 APAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 43 STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 44 STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2017–2024 (USD MILLION)
TABLE 45 NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 46 EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 47 APAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 48 STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2017–2024 (USD MILLION)
TABLE 49 NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 50 EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 51 APAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 52 STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2015–2022 (USD MILLION)
TABLE 53 NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 54 EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 55 APAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 56 STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR OTHER END USERS, BY REGION, 2015–2022 (USD MILLION)
TABLE 57 NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR OTHER END USERS, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 58 EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR OTHER END USERS, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 59 APAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR OTHER END USERS, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 60 STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 61 NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 62 NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 63 NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 64 NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 65 US: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 66 US: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 67 US: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 68 CANADA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD THOUSAND)
TABLE 69 CANADA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD THOUSAND)
TABLE 70 CANADA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD THOUSAND)
TABLE 71 EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 72 EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 73 EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 74 EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 75 GERMANY: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 76 GERMANY: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 77 GERMANY: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 78 UK: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 79 UK: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 80 UK: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 81 FRANCE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD THOUSAND)
TABLE 82 FRANCE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD THOUSAND)
TABLE 83 FRANCE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2015–2022 (USD THOUSAND)
TABLE 84 ITALY: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD THOUSAND)
TABLE 85 ITALY: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD THOUSAND)
TABLE 86 ITALY: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD THOUSAND)
TABLE 87 SPAIN: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD THOUSAND)
TABLE 88 SPAIN: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD THOUSAND)
TABLE 89 SPAIN: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD THOUSAND)
TABLE 90 PHARMACEUTICAL R&D EXPENDITURE IN ROE COUNTRIES (2016)
TABLE 91 ROE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD THOUSAND)
TABLE 92 ROE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD THOUSAND)
TABLE 93 ROE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD THOUSAND)
TABLE 94 NUMBER OF NUCLEAR REACTORS IN THE ASIA PACIFIC (AUGUST 2019)
TABLE 95 ASIA PACIFIC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 96 ASIA PACIFIC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 97 ASIA PACIFIC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 98 ASIA PACIFIC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE 99 CHINA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 100 CHINA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 101 CHINA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 102 JAPAN: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD THOUSAND)
TABLE 103 JAPAN: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2015–2022 (USD THOUSAND)
TABLE 104 JAPAN: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD THOUSAND)
TABLE 105 INDIA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD THOUSAND)
TABLE 106 INDIA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD THOUSAND)
TABLE 107 INDIA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD THOUSAND)
TABLE 108 AUSTRALIA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD THOUSAND)
TABLE 109 AUSTRALIA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD THOUSAND)
TABLE 110 AUSTRALIA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD THOUSAND)
TABLE 111 ROAPAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD THOUSAND)
TABLE 112 ROAPAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD THOUSAND)
TABLE 113 ROAPAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD THOUSAND)
TABLE 114 ROW: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD THOUSAND)
TABLE 115 ROW: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD THOUSAND)
TABLE 116 ROW: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD THOUSAND)
TABLE 117 AGREEMENTS (2016–2019)
TABLE 118 PRODUCT LAUNCHES (2016-2019)
LIST OF FIGURES
FIGURE 1 RESEARCH DESIGN
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 4 MARKET SIZE ESTIMATION: STABLE ISOTOPE-LABELED COMPOUNDS MARKET
FIGURE 5 MARKET DATA TRIANGULATION METHODOLOGY
FIGURE 6 STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2019 VS. 2024 (USD MILLION)
FIGURE 7 STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2019 VS. 2024 (USD MILLION)
FIGURE 8 STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2019 VS. 2024 (USD MILLION)
FIGURE 9 GEOGRAPHIC SNAPSHOT OF THE STABLE ISOTOPE-LABELED COMPOUNDS MARKET
FIGURE 10 INCREASE IN RESEARCH IN THE PHARMACEUTICAL & BIOTECHNOLOGY SECTORS WILL DRIVE MARKET GROWTH
FIGURE 11 RESEARCH APPLICATIONS ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN MARKET IN 2018
FIGURE 12 NORTH AMERICA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
FIGURE 13 STABLE ISOTOPE-LABELED COMPOUNDS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 14 NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET SNAPSHOT
FIGURE 15 ASIA PACIFIC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET SNAPSHOT
FIGURE 16 MARKET RANKING OF KEY PLAYERS, 2018
FIGURE 17 COMPETITIVE LEADERSHIP MAPPING: STABLE ISOTOPE-LABELED COMPOUNDS MARKET
FIGURE 18 MERCK KGAA: COMPANY SNAPSHOT
FIGURE 19 URENCO LIMITED: COMPANY SNAPSHOT (2018)
FIGURE 20 TAIYO NIPPON SANSO CORPORATION: COMPANY SNAPSHOT (2018)
FIGURE 21 PERKINELMER: COMPANY SNAPSHOT (2018)
FIGURE 1 RESEARCH DESIGN
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 4 MARKET SIZE ESTIMATION: STABLE ISOTOPE-LABELED COMPOUNDS MARKET
FIGURE 5 MARKET DATA TRIANGULATION METHODOLOGY
FIGURE 6 STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2019 VS. 2024 (USD MILLION)
FIGURE 7 STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2019 VS. 2024 (USD MILLION)
FIGURE 8 STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2019 VS. 2024 (USD MILLION)
FIGURE 9 GEOGRAPHIC SNAPSHOT OF THE STABLE ISOTOPE-LABELED COMPOUNDS MARKET
FIGURE 10 INCREASE IN RESEARCH IN THE PHARMACEUTICAL & BIOTECHNOLOGY SECTORS WILL DRIVE MARKET GROWTH
FIGURE 11 RESEARCH APPLICATIONS ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN MARKET IN 2018
FIGURE 12 NORTH AMERICA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
FIGURE 13 STABLE ISOTOPE-LABELED COMPOUNDS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 14 NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET SNAPSHOT
FIGURE 15 ASIA PACIFIC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET SNAPSHOT
FIGURE 16 MARKET RANKING OF KEY PLAYERS, 2018
FIGURE 17 COMPETITIVE LEADERSHIP MAPPING: STABLE ISOTOPE-LABELED COMPOUNDS MARKET
FIGURE 18 MERCK KGAA: COMPANY SNAPSHOT
FIGURE 19 URENCO LIMITED: COMPANY SNAPSHOT (2018)
FIGURE 20 TAIYO NIPPON SANSO CORPORATION: COMPANY SNAPSHOT (2018)
FIGURE 21 PERKINELMER: COMPANY SNAPSHOT (2018)
